Cancer Family

Hematopoietic and Lymphatic System Neoplasm

Non-malignant4,304 active trials98 approved drugs1,010 evidence items

NCIt: C35813

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (736)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 126–150 of 736 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Timing matters: Impact of covalent BTK inhibitor dose modifications on outcomes in chronic lymphocytic leukemia/small lymphocytic leukemia-A 7-year real-world study.
Jiaojiao Zhang, Jing Luo, Xiaozhong Shen et al. · Cancer · Sep 15, 2026 · PMID 42740716 · candidate dictionary pubmed
Investigational Clinical Trial Agents versus Conventional Second Salvage Therapies in Patients with Relapsed/Refractory Acute Myeloid Leukemia.
Daniel Nguyen, Hagop M Kantarjian, Aram Bidikian et al. · Clin Cancer Res · Sep 15, 2026 · PMID 42329225 · candidate dictionary pubmed
Imaging B cell maturation antigen in multiple myeloma.
Yangmeihui Song, Wenyu Song, Weibo Cai · J Clin Invest · Sep 15, 2026 · PMID 42741935 · candidate dictionary pubmed
A single-arm prospective phase I trial of 68Ga-PFBC01 PET/CT for multiple myeloma B cell maturation antigen imaging.
Tingfei Gu, Zhao Chen, Bo Tang et al. · J Clin Invest · Sep 15, 2026 · PMID 42378054 · candidate dictionary pubmed
Second Primary Malignancy Risk in Patients with Multiple Myeloma Receiving CAR T-cell Therapy or Other Systemic Anticancer Treatments: A Real-World Comparative Study.
Attaya Suvannasankha, Mengying Li, Omonefe Omofuma et al. · Clin Cancer Res · Sep 15, 2026 · PMID 42283723 · candidate dictionary pubmed
Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma.
Rafael R Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads et al. · Cancer Res · Sep 15, 2026 · PMID 42233980 · candidate dictionary

pubmed

Non-genetic remodeling drives leukemia propagation and reveals actionable vulnerabilities in acute myeloid leukemia.

Clement Larrue, Paolo Angelino, Sarah Mouche et al. · Cell Rep Med · Sep 15, 2026 · PMID 42673946 · candidate dictionary pubmed

Early deep response to cilta-cel as 2nd CAR T-Cell therapy after CELMoD-based bridging for advanced multiple myeloma.

Henrik Niklas, Anna Bold, Simon Völkl et al. · Ann Hematol · Sep 15, 2026 · PMID 42747560 · candidate dictionary pubmed

Outcomes of down syndrome-related myeloid leukemia in Turkiye: a multicenter retrospective observational cohort study by the Turkish Pediatric Hematology Association.

Yeter Düzenli Kar, Hale Ören, Melike Sezgin Evim et al. · Ann Hematol · Sep 15, 2026 · PMID 42752662 · candidate dictionary pubmed

Outcomes of stereotactic radiosurgery for spine multiple myeloma-a systematic review.

Muhammad Izhar, Yusuke S Hori, Ahed H Kattaa et al. · Neurosurg Rev · Sep 14, 2026 · PMID 42733030 · candidate dictionary pubmed

Multiple Myeloma-Derived Cellular Lipids Enhance Targeting and Efficacy of Nanoliposome Formulations In Vitro.

Mathew Amorin, Christina Tran, Eden Park et al. · Int J Mol Sci · Sep 13, 2026 · PMID 42794583 · candidate dictionary pubmed

Global prevalence trends and predictions of Hodgkin lymphoma from 1990 to 2021: age-period-cohort analysis and transnational inequality.

Wei-Li Wang, Shen-Sui Li, Dan Ma et al. · J Glob Health · Sep 11, 2026 · PMID 42726074 · candidate dictionary pubmed

Hospital at home enables safe and efficient outpatient management of intensively treated acute myeloid leukemia.

Kristina Warolén, Ola Blennow, Anna Ravn Landtblom et al. · Support Care Cancer · Sep 10, 2026 · PMID 42720797 · candidate dictionary pubmed

Response to alemtuzumab-based therapy and long-term survival after allogeneic transplantation in T-Cell prolymphocytic leukemia: a systematic review and meta-analysis of proportions.

Jamiel Reyes, Alexander Reyes · Eur J Clin Pharmacol · Sep 10, 2026 · PMID 42720768 · candidate dictionary pubmed

From pumps to networks: ABC transporters in leukemia resistance and microenvironmental adaptation.

Jyotirmayee, Veerandra Kumar, Malkhey Verma · Med Oncol · Sep 10, 2026 · PMID 42720707 · candidate dictionary pubmed

Inhibition of the atypical kinase WNK1 as a therapeutic strategy in TAL-related T-cell acute lymphoblastic leukemia.

Anna Montanaro, Gregorio Monica, Raffaella Zamponi et al. · Blood · Sep 10, 2026 · PMID 42154791 · candidate dictionary pubmed

Treatment Decisions in Multiple Myeloma.

Tarek H Mouhieddine, Kenneth C Anderson · N Engl J Med · Sep 10, 2026 · PMID 42715563 · candidate dictionary pubmed

Product-intrinsic NF-κB-driven transcriptional programs connote durability of CAR-T response in multiple myeloma.

Jerald D Noble, Barbara C Peixoto, Meghan A Menges et al. · Blood · Sep 10, 2026 · PMID 42275255 · candidate dictionary pubmed

Five-year survival outcomes of lisocabtagene maraleucel in R/R LBCL from the TRANSCEND NHL 001 study.

Jeremy S Abramson, Tanya Siddiqi, Leo I Gordon et al. · Blood · Sep 10, 2026 · PMID 42237652 · candidate dictionary pubmed

Integrative pooled transcriptomic analysis reveals shared and distinct molecular signatures in adult T-cell leukemia/lymphoma and peripheral T-cell lymphoma.

Mohammad Mehdi Akbarin, Zahra Farjami, Hugo Ramírez Álvarez · Funct Integr Genomics · Sep 9, 2026 · PMID 42714615 · candidate dictionary pubmed

Cone-Beam Computed Tomography Imaging of Primary Non-Hodgkin Lymphoma of the Jaws: A 6-Case Series.

Emmanouil Chatzipetros, Konstantina-Eleni Alexiou, Kostas Tsiklakis et al. · Am J Case Rep · Sep 9, 2026 · PMID 42715158 · candidate dictionary pubmed

The Epigenetic Architecture of Classical Hodgkin Lymphoma: Lineage Erasure, Immune Escape, and Therapeutic Reprogramming.

Matei Seleusan, Diana Cenariu, Adrian-Bogdan Țigu et al. · Medicina (Kaunas) · Sep 9, 2026 · PMID 42796346 · candidate dictionary pubmed

AML1-ETO hijacks a distal enhancer of NAT10 to reprogram glutathione metabolism and sustain leukemia stem cell stemness.

Shuyi Li, Shujiao He, Yongwei Su et al. · Proc Natl Acad Sci U S A · Sep 8, 2026 · PMID 42679037 · candidate dictionary pubmed

Real-world outcomes with BCMA- and GPRC5D-targeting bispecific antibodies in plasma cell leukemia.

Mahmoud R Gaballa, Kelley Julian, Aimaz Afrough et al. · Blood Adv · Sep 8, 2026 · PMID 42392158 · candidate dictionary pubmed

Minimal residual disease by high-throughput sequencing in standard risk-favorable pediatric B-lymphoblastic leukemia.

Carol Fries, Lingyun Ji, Meenakshi Devidas et al. · Blood Adv · Sep 8, 2026 · PMID 42348788 · candidate dictionary pubmed